These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1180 related items for PubMed ID: 11212278

  • 1. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P, Stewart AJ, Dangerfield W, Okiji S, Liddle C, Bootle D, Plumb JA, Templeton D, Charlton P.
    Cancer Res; 2001 Jan 15; 61(2):749-58. PubMed ID: 11212278
    [Abstract] [Full Text] [Related]

  • 2. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ, Rodarte JC, Benbatoul KD, Romano SJ, Zhang C, Krane S, Moran EJ, Uyeda RT, Dixon R, Guns ES, Mayer LD.
    Cancer Res; 2000 Jun 01; 60(11):2964-72. PubMed ID: 10850444
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.
    Dantzig AH, Shepard RL, Cao J, Law KL, Ehlhardt WJ, Baughman TM, Bumol TF, Starling JJ.
    Cancer Res; 1996 Sep 15; 56(18):4171-9. PubMed ID: 8797588
    [Abstract] [Full Text] [Related]

  • 7. Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol.
    Christensen JG, LeBlanc GA.
    Cancer Res; 1996 Feb 01; 56(3):574-81. PubMed ID: 8564974
    [Abstract] [Full Text] [Related]

  • 8. Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue.
    Chen LM, Liang YJ, Zhang X, Su XD, Dai CL, Wang FP, Yan YY, Tao LY, Fu LW.
    Anticancer Res; 2009 Nov 01; 29(11):4597-604. PubMed ID: 20032409
    [Abstract] [Full Text] [Related]

  • 9. A New Class of Safe, Potent, and Specific P-gp Modulator: Flavonoid Dimer FD18 Reverses P-gp-Mediated Multidrug Resistance in Human Breast Xenograft in Vivo.
    Yan CS, Wong IL, Chan KF, Kan JW, Chong TC, Law MC, Zhao Y, Chan SW, Chan TH, Chow LM.
    Mol Pharm; 2015 Oct 05; 12(10):3507-17. PubMed ID: 26291333
    [Abstract] [Full Text] [Related]

  • 10. Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.
    Dale IL, Tuffley W, Callaghan R, Holmes JA, Martin K, Luscombe M, Mistry P, Ryder H, Stewart AJ, Charlton P, Twentyman PR, Bevan P.
    Br J Cancer; 1998 Oct 05; 78(7):885-92. PubMed ID: 9764579
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918.
    Wallstab A, Koester M, Böhme M, Keppler D.
    Br J Cancer; 1999 Mar 05; 79(7-8):1053-60. PubMed ID: 10098736
    [Abstract] [Full Text] [Related]

  • 12. The chemosensitizing potential of GF120918 is independent of the magnitude of P-glycoprotein-mediated resistance to conventional chemotherapeutic agents in a small cell lung cancer line.
    Myer MS, Joone G, Chasen MR, van Rensburg CE.
    Oncol Rep; 1999 Mar 05; 6(1):217-8. PubMed ID: 9864431
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis.
    Jin J, Sun H, Wei H, Liu G.
    Invest New Drugs; 2007 Apr 05; 25(2):95-105. PubMed ID: 16937080
    [Abstract] [Full Text] [Related]

  • 15. Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP.
    Germann UA, Ford PJ, Shlyakhter D, Mason VS, Harding MW.
    Anticancer Drugs; 1997 Feb 05; 8(2):141-55. PubMed ID: 9073310
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein.
    Martin C, Berridge G, Mistry P, Higgins C, Charlton P, Callaghan R.
    Br J Pharmacol; 1999 Sep 05; 128(2):403-11. PubMed ID: 10510451
    [Abstract] [Full Text] [Related]

  • 18. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
    Jin J, Wang FP, Wei H, Liu G.
    Cancer Chemother Pharmacol; 2005 Feb 05; 55(2):179-88. PubMed ID: 15378274
    [Abstract] [Full Text] [Related]

  • 19. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells.
    Fu LW, Zhang YM, Liang YJ, Yang XP, Pan QC.
    Eur J Cancer; 2002 Feb 05; 38(3):418-26. PubMed ID: 11818209
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.
    Hyafil F, Vergely C, Du Vignaud P, Grand-Perret T.
    Cancer Res; 1993 Oct 01; 53(19):4595-602. PubMed ID: 8402633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.